Pictet Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$995K Buy
8,449
+905
+12% +$126K ﹤0.01% 1111
2025
Q4
$1.24M Buy
7,544
+308
+4% +$48.2K ﹤0.01% 1029
2025
Q3
$967K Sell
7,236
-767
-10% -$93.2K ﹤0.01% 1079
2025
Q2
$995K Sell
8,003
-333
-4% -$42.4K ﹤0.01% 1063
2025
Q1
$1.06M Buy
8,336
+457
+6% +$70.3K ﹤0.01% 1038
2024
Q4
$1.13M Buy
7,879
+992
+14% +$142K ﹤0.01% 1031
2024
Q3
$1.02M Sell
6,887
-16,208
-70% -$2.32M ﹤0.01% 1031
2024
Q2
$2.91M Sell
23,095
-8
-0% -$1.25K ﹤0.01% 852
2024
Q1
$4.25M Buy
23,103
+1,512
+7% +$288K ﹤0.01% 811
2023
Q4
$3.88M Sell
21,591
-363
-2% -$56.5K ﹤0.01% 830
2023
Q3
$3.49M Buy
+21,954
New +$3.59M ﹤0.01% 841

Other funds holding RGEN

Pictet Asset Management's RGEN Position: Q1 2026 in Review

Pictet Asset Management increased its Repligen (RGEN) stake by 12% in Q1 2026, buying an estimated $126K and bringing the position to 8,449 shares worth $995K. The position accounts for ﹤0.01% of the portfolio, ranked #1111.

Pictet Asset Management first reported a position in RGEN in Q3 2023 and has held it in 11 quarters since. The position peaked at $4.25M in Q1 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Pictet Asset Management held 8,449 shares of Repligen worth $995K as of Q1 2026.
  • Pictet Asset Management bought 905 Repligen shares in Q1 2026, an estimated $126K.
  • Repligen made up ﹤0.01% of Pictet Asset Management's portfolio in Q1 2026, its #1111 holding.
  • Pictet Asset Management first reported a position in Repligen in Q3 2023 and has held it in 11 quarters since.
  • Pictet Asset Management's Repligen position peaked at $4.25M in Q1 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.